Prothrombin G20210A Mutation and Lower Extremity Peripheral Arterial Disease: A Systematic Review and Meta-analysis
- 1 August 2015
- journal article
- research article
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 50 (2) , 232-240
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Research and Innovation's Early Researcher Award
This publication has 30 references indexed in Scilit:
- Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic AttackStroke, 2014
- Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood typeCanadian Medical Association Journal, 2013
- Is Thrombophilia Testing Useful?Hematology-American Society Hematology Education Program, 2011
- Clinical guidelines for testing for heritable thrombophiliaBritish Journal of Haematology, 2010
- Thrombophilic risk factors and peripheral arterial disease severityThrombosis and Haemostasis, 2010
- Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: The Linz Peripheral Arterial Disease (LIPAD) studyJournal of Vascular Surgery, 2005
- Thrombophilic risk factors for symptomatic peripheral arterial diseaseJournal of Vascular Surgery, 2005
- The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case–control studyJournal of Thrombosis and Haemostasis, 2004
- Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort studyThe Lancet, 2003
- Geographic Distribution of the 20210 G to A Prothrombin VariantThrombosis and Haemostasis, 1998